10x Genomics (TXG) Insider Trading & Ownership $22.08 +0.67 (+3.13%) (As of 09/18/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends 10x Genomics (NASDAQ:TXG) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.03%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$2.66 M Get TXG Insider Trade Alerts Want to know when executives and insiders are buying or selling 10x Genomics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TXG Insider Buying and Selling by Quarter Ad GreenlaneThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start with diversification and experience. Founded in 2005, this company serves a diverse and expansive customer base with more than 8,000 retail locations, including licensed cannabis dispensaries, smoke shops, and specialty retailers. Learn more here. 10x Genomics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/22/2024Benjamin J HindsonInsiderSell4,351$22.53$98,028.03 8/22/2024Justin J McanearCFOSell2,961$22.53$66,711.33 8/22/2024Serge SaxonovCEOSell6,749$22.53$152,054.97 5/22/2024Benjamin J HindsonInsiderSell4,087$24.30$99,314.10 5/22/2024Justin J McanearCFOSell2,936$24.30$71,344.80 5/22/2024Serge SaxonovCEOSell4,877$24.30$118,511.10 This diversified cannabis pioneer could make huge moves soon (Ad)The cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start with diversification and experience. Founded in 2005, this company serves a diverse and expansive customer base with more than 8,000 retail locations, including licensed cannabis dispensaries, smoke shops, and specialty retailers. Learn more here.3/4/2024Serge SaxonovCEOSell4,660$44.00$205,040.00 2/22/2024Benjamin J HindsonInsiderSell2,613$46.34$121,086.42 2/22/2024Justin J McanearCFOSell1,865$46.34$86,424.10 2/22/2024Serge SaxonovCEOSell2,821$46.34$130,725.14 2/9/2024Serge SaxonovCEOSell1,000$49.53$49,530.00 1/16/2024Serge SaxonovCEOSell4,000$45.24$180,960.00 12/14/2023Serge SaxonovCEOSell2,000$55.03$110,060.00 11/24/2023Serge SaxonovCEOSell3,723$43.72$162,769.56 11/22/2023James WilburInsiderSell3,464$43.34$150,129.76 11/22/2023Justin J McanearCFOSell1,679$43.34$72,767.86 11/22/2023Serge SaxonovCEOSell3,757$43.34$162,828.38 11/20/2023James WilburInsiderSell14,718$42.09$619,480.62 10/16/2023Serge SaxonovCEOSell21$39.50$829.50 (Data available from 1/1/2013 forward) TXG Insider Trading Activity - Frequently Asked Questions Who is on 10x Genomics's Insider Roster? The list of insiders at 10x Genomics includes Benjamin J Hindson, Bradford Crutchfield, James Wilbur, John R Stuelpnagel, Justin J Mcanear, Mathai Mammen, Serge Saxonov, and Sridhar Kosaraju. Learn more on insiders at TXG. What percentage of 10x Genomics stock is owned by insiders? 10.03% of 10x Genomics stock is owned by insiders. Learn more on TXG's insider holdings. Which 10x Genomics insiders have been selling company stock? The following insiders have sold TXG shares in the last 24 months: Benjamin J Hindson ($1,883,953.50), James Wilbur ($1,213,630.60), John R Stuelpnagel ($548,900.00), Justin J Mcanear ($580,588.40), Mathai Mammen ($1,743,060.00), and Serge Saxonov ($4,819,344.30). How much insider selling is happening at 10x Genomics? Insiders have sold a total of 221,572 10x Genomics shares in the last 24 months for a total of $10,789,476.80 sold. 10x Genomics Key ExecutivesDr. Serge Saxonov Ph.D. (Age 47)Co-Founder, CEO & Director Compensation: $925.05kDr. Benjamin J. Hindson Ph.D. (Age 49)Co-Founder, President, Chief Scientific Officer & Director Compensation: $618.32kMr. Eric S. Whitaker Esq. (Age 57)Chief Legal Officer Compensation: $615.38kMr. Michael Schnall-LevinFounding Scientist & CTOMs. Cassie CorneauManager of Investor Relations and Strategic FinanceMs. Rebecca PortChief People OfficerMr. Jens DurruthyAssociate Director of Product Management More Insider Trading Tools from MarketBeat Related Companies: Bruker Insider Selling Bio-Rad Laboratories Insider Selling Standard BioTools Insider Selling Cytek Biosciences Insider Selling Quanterix Insider Selling Pacific Biosciences of California Insider Selling EyePoint Pharmaceuticals Insider Selling Nautilus Biotechnology Insider Selling Akoya Biosciences Insider Selling Harvard Bioscience Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:TXG) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding 10x Genomics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share 10x Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
